Palvella Therapeutics, Inc. (PVLA)
150.68
-3.64
(-2.36%)
USD |
NASDAQ |
Sep 18, 16:00
150.68
0.00 (0.00%)
After-Hours: 19:58
Palvella Therapeutics Debt to Equity Ratio : 0.1044 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1044 |
| March 31, 2026 | 0.0877 |
| December 31, 2025 | 0.6573 |
| September 30, 2025 | 0.4142 |
| June 30, 2025 | 0.3037 |
| March 31, 2025 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.4029 |
| June 30, 2023 | 0.3168 |
| March 31, 2023 | 0.8467 |
| December 31, 2022 | 0.4692 |
| September 30, 2022 | 0.3416 |
| June 30, 2022 | 0.2986 |
| March 31, 2022 | 0.2688 |
| December 31, 2021 | 0.2934 |
| September 30, 2021 | 0.278 |
| June 30, 2021 | 0.3407 |
| March 31, 2021 | 0.4173 |
| December 31, 2020 | 0.5467 |
| September 30, 2020 | 0.3745 |
| June 30, 2020 | 0.3404 |
| March 31, 2020 | 0.3167 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.3158 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.0414 |
| September 30, 2014 | -1.507 |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 5.874 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 253.51M |
| Total Liabilities (Quarterly) | 36.64M |
| Shareholders Equity (Quarterly) | 216.87M |
| Current Ratio | 21.18 |
| Net Debt Paydown Yield | -0.21% |